H1N1 vaccine Focetria receives positive opinion from CHMP

Novartis A(H1N1) Pandemic Influenza vaccine Focetria? receives positive opinion from CHMP – Novartis announced that Focetria, the Novartis Influenza A(H1N1) 2009 monovalent vaccine, has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA).

Health Newstrack